BRCA2 Mutation Should be Screened Routinely and Early as a Poor Prognostic Biomarker in Prostate Cancer Patients With a Family History of Cancer
2017 ◽
Vol 99
(2)
◽
pp. E225-E226
Keyword(s):
2016 ◽
Vol 34
(10)
◽
pp. 531-535
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
1995 ◽
Vol 60
(3)
◽
pp. 361-364
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 18
(5)
◽
pp. e1217-e1227
◽
Keyword(s):
1995 ◽
Vol 1
(6)
◽
pp. 240-245
◽
Keyword(s):